After a routine blood test 15 years ago revealed ESPN Radio Host Mike Golic had type 2 diabetes—a disease that also impacted his father—Golic began his journey of learning to live with and manage a chronic condition. Find out what this former NFL player considers one of the most important factors for successfully managing diabetes, what he relies on his family for and why he has no intention of giving up donuts anytime soon.
Mannkind Corporation is the first and currently only maker of inhalable insulin. Their CCO Michael Castagna, a PharmD, answers a bunch of questions about Afrezza, including how it works, why users like it, and what the concerns are around long-term side effects.